These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2991815)

  • 1. Angiotensin converting enzyme in cerebrospinal fluid: a new assay.
    Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C
    Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis.
    Jones DB; Mitchell D; Horn DB; Edwards CR
    Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin I-converting enzyme in cerebrospinal fluid and neurosarcoidosis].
    Baudin B; Bénéteau-Burnat B; Vaubourdolle M
    Ann Biol Clin (Paris); 2005; 63(5):475-80. PubMed ID: 16230281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF angiotensin-converting enzyme in neurosarcoidosis.
    Chan Seem CP; Norfolk G; Spokes EG
    Lancet; 1985 Feb; 1(8426):456-7. PubMed ID: 2857830
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF angiotensin-converting enzyme in neurosarcoidosis.
    Oksanen V; Fyhrquist F; Grönhagen-Riska C; Somer H
    Lancet; 1985 May; 1(8436):1050-1. PubMed ID: 2859505
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis.
    Dale JC; O'Brien JF
    Mayo Clin Proc; 1999 May; 74(5):535. PubMed ID: 10319092
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid lysozyme and beta 2-microglobulin in neurosarcoidosis.
    Oksanen V; Grönhagen-Riska C; Tikanoja S; Somer H; Fyhrquist F
    J Neurol Sci; 1986 Mar; 73(1):79-87. PubMed ID: 3517236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.
    Bridel C; Courvoisier DS; Vuilleumier N; Lalive PH
    J Neuroimmunol; 2015 Aug; 285():1-3. PubMed ID: 26198911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis.
    Khoury J; Wellik KE; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2009 Mar; 15(2):108-11. PubMed ID: 19276791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
    Arun T; Pattison L; Palace J
    Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF-ACE activity in probable CNS neurosarcoidosis.
    Tahmoush AJ; Amir MS; Connor WW; Farry JK; Didato S; Ulhoa-Cintra A; Vasas JM; Schwartzman RJ; Israel HL; Patrick H
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):191-7. PubMed ID: 12405488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.
    Marangoni S; Argentiero V; Tavolato B
    J Neurol; 2006 Apr; 253(4):488-95. PubMed ID: 16283095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.
    Otto C; Wengert O; Unterwalder N; Meisel C; Ruprecht K
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32393650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond biopsy for neurosarcoidosis: A review of blood and CSF biomarkers.
    Lackey E; Shen J; Sharma A; Eckstein C
    J Neuroimmunol; 2024 Aug; 393():578394. PubMed ID: 38875863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis.
    Scott TF; Seay AR; Goust JM
    Neurology; 1989 Dec; 39(12):1637-9. PubMed ID: 2586781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic manifestations and enzyme studies in sarcoidosis with neurologic involvement.
    Oksanen V; Grönhagen-Riska C; Fyhrquist F; Somer H
    Acta Med Scand; 1985; 218(1):123-7. PubMed ID: 2996309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.
    Sakushima K; Yabe I; Nakano F; Yoshida K; Tajima Y; Houzen H; Maruo Y; Sasaki H
    J Neurol; 2011 Dec; 258(12):2163-7. PubMed ID: 21553080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosarcoidosis: clinical experience and diagnostic pitfalls.
    Kellinghaus C; Schilling M; Lüdemann P
    Eur Neurol; 2004; 51(2):84-8. PubMed ID: 14752214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosarcoidosis: clinical presentations and course in 50 patients.
    Oksanen V
    Acta Neurol Scand; 1986 Mar; 73(3):283-90. PubMed ID: 3716768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis].
    Baudin B
    Pathol Biol (Paris); 2005 Apr; 53(3):183-8. PubMed ID: 15781381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.